There are two other phase II studies that are completed in patients with R/R primary central nervous system lymphoma (PCNSL) and advanced lymphoma and HNSCC harboring NOTCH1 loss of function mutations [394,395,396]. The gene discussed is NOTCH1; the disease is primary central nervous system lymphoma.